The Pentagon rescinded mandatory testosterone screening guidance for service members less than 24 hours after posting it, a stumble that raises fresh questions about administrative discipline inside the Department of Defense.
On Wednesday, the Defense Department published a document titled "Clinical Guidance for Health and Human Performance Optimization" on its website, alongside an accompanying statement from Pentagon spokesperson Sean Parnell. By Thursday, both the memo and Parnell's statement had vanished. Links on the Pentagon and Defense Health Agency websites returned "Page Not Found" errors, as Reuters first reported.
A U.S. official confirmed the reversal to Reuters, calling the document a draft that had been "temporarily rescinded to allow for updates." The official added that interim guidance remains in effect, though the Pentagon has not publicly detailed what that interim guidance says or how it differs from the document that was pulled.
Defense Secretary Pete Hegseth had personally promoted the testosterone screening initiative in a social media video in July, framing it as a readiness measure, not a performance-enhancement scheme. In that video, Hegseth said the program was "about restoring and optimizing your natural capabilities, protecting your longevity and ensuring you have the biological foundation required to sustain the fight."
The concept was straightforward enough. Under the now-rescinded guidance, male service members aged 30 and older would receive a questionnaire during their annual health assessments. Answers flagging potential testosterone deficiency could trigger a blood test and, if warranted, hormone therapy. Women would undergo a separate screening track for hormonal imbalances, with testosterone treatment limited to diagnoses backed by clinical evidence, one example cited was Hypoactive Sexual Desire Disorder, a condition marked by persistently low sexual interest.
The guidance was set to take effect immediately upon publication. That urgency makes the next-day pullback harder to explain. If the document needed updates, it should not have been posted as final clinical policy in the first place.
Hegseth's broader tenure at the Pentagon has been marked by internal friction and high-profile departures, and the testosterone program's chaotic debut fits a pattern of ambitious policy goals running into sloppy execution.
The program had already drawn scrutiny before Wednesday's botched rollout. Critics raised concerns about artificial performance enhancement and potential fertility risks tied to testosterone therapy, objections the Pentagon evidently did not resolve before hitting "publish." The Washington Examiner noted that the guidance's provisions for screening female service members had not been publicly emphasized before the document appeared, catching observers off guard.
A Pentagon spokesperson offered a carefully worded reassurance after the pullback, stating that "the Department remains committed to addressing hormone deficiencies, protecting the long-term health of its Service members, and enabling peak operational performance." That language echoed Hegseth's July pitch almost word for word, but commitment and competence are different things.
Hegseth had branded the initiative the "High-T Department of War," a label designed to project strength. Instead, the 24-hour lifecycle of the guidance projected the opposite. Just The News reported that the testosterone screening policy was part of a broader package of military reforms under Hegseth, including requiring women in combat roles to meet the same physical standards as men.
That broader reform agenda has merit. Holding all combat personnel to equal standards is common sense. Identifying hormone deficiencies that degrade readiness is a legitimate medical objective. But good ideas executed badly become ammunition for opponents, and the Pentagon handed critics exactly that.
The testosterone screening debacle did not happen in a vacuum. Hegseth has faced sustained pressure from multiple directions during his time leading the Defense Department. Top military leaders warned him that certain operational deployments were unsustainable, adding strain to an already demanding portfolio.
On Capitol Hill, Democratic lawmakers have seized on every stumble. Rep. Ted Lieu publicly demanded Hegseth's resignation over separate policy disputes, part of a broader effort by the left to undermine the defense secretary's standing. Those calls predated the testosterone guidance fiasco but will only grow louder now.
Meanwhile, legal challenges from fired Stars and Stripes journalists alleging First Amendment retaliation have added another front to the political conflict surrounding Hegseth's Pentagon.
None of these pressures excuse the basic administrative failure of publishing clinical guidance the department was not ready to stand behind. The unnamed U.S. official's characterization of the document as a "draft" raises an obvious question: who approved posting a draft as if it were final policy, and what accountability follows?
Several gaps remain. The Pentagon has not explained what specific updates prompted the rescission. It has not released the text of the interim guidance it says remains in effect. It has not clarified whether any service members or military medical personnel acted on the guidance during the hours it was live. And it has not said whether Sean Parnell's accompanying statement, also scrubbed from the website, will be reissued.
Breitbart reported that the policy page was simply replaced with a "Page Not Found" error, with no public notice or explanation posted in its place. That is not how a serious institution communicates a policy change to the men and women it expects to follow orders.
Hegseth's instinct on military readiness, that the force should be physically optimized and held to high standards, aligns with what most Americans expect from their military. The problem is not the goal. The problem is a Defense Department apparatus that published binding clinical guidance it had to yank within a day, then offered a two-sentence explanation and went quiet.
If the Pentagon wants service members to trust its medical directives, it might start by making sure those directives survive their first 24 hours.